LG Life Sciences eyes M&A with GeneSoft within this year

LG Life Sciences might take its M&A bid to the US-based GeneSoft within this year to independently promote Factive in the global market due to the approval of additional indications, such as PRSP (Penicillin-resistant S. Pneumoniae) and MDRSP (multidrug- resistant Pneumoniae) from the US FDA, according to an analyst at a major domestic brokerage.

LG Life Sciences may expect its appraisal gai...